This is one of the most-searched questions in the 7-OH category, and it is the one where we are going to be unusually blunt: there is no reliable, citable detection window for 7-hydroxymitragynine, and anyone publishing precise hours or days is selling confidence, not data. Here is what the chemistry actually supports, why the gap exists, and what in-your-system even means in practice. And to be clear up front: nothing in this post is advice about evading any test, and we will not publish that kind of content under any framing.
Why exact numbers do not exist (yet)
For a compound to have a published detection window, you need pharmacokinetic studies in humans and validated screening methods for that specific compound. For 7-hydroxymitragynine:
- Human pharmacokinetic studies are limited compared to the classical opioid literature.
- Standard drug-screen immunoassays are built around specific target molecules; 7-OH cross-reactivity with those screens is not a settled, universally published fact.
- Confirmatory testing (for example mass spectrometry) can target 7-OH when specifically requested, but routine panels may not include it.
That is the whole picture: limited human PK data, no settled routine-panel status, and no vendor-verified detection chart. Any claim that 7-OH is out of your system in a fixed number of hours is extrapolation, and we will not extrapolate either.
What in your system can mean
Because people use the phrase three different ways, the honest answer branches:
| Meaning | What we can say |
|---|---|
| How long do the effects last? | That is a duration question — covered with ranges in our how long does 7-OH last guide (commonly several hours, wide individual range). |
| How long until the compound is metabolized? | Unknown to a publishable precision. Metabolism follows individual physiology; no reliable chart exists. |
| Will a drug test detect it? | Depends on what the test is built to detect and whether it specifically targets 7-OH. We do not advise on test outcomes and will not guess your panel. |
If you have a real testing obligation — employment, legal, medical — the only defensible position is to not use 7-OH (or any untested alkaloid product) in a way that puts you at risk of a result you cannot explain, and to talk to a professional about your specific situation. That is the responsible-use line from our responsible use guide, applied to this exact question.
What the compound chemistry does tell us
A few structural facts are real and worth knowing, even without detection charts:
- 7-hydroxymitragynine is metabolized in the body like other lipophilic alkaloids — absorption, distribution, metabolism, and elimination all follow individual physiology.
- It binds opioid receptors (the mechanism in our how 7-OH works post), which is why regulatory and testing attention is growing as 2026 legal changes roll out.
- Regular use changes the picture versus single use — tolerance, accumulation, and the taper questions in our tapering guide — which is another reason continuous, daily use is the pattern to avoid.
Why we publish the we-do-not-know
Most vendor content in this space either invents detection numbers (to reassure buyers) or dodges the question entirely (to avoid liability). Both fail the buyer. The version that respects you: the data is not there, the testing landscape is moving, and your obligations are yours to manage with professionals. If a job, a legal matter, or a medical situation makes this question real for you, the correct next step is a doctor or a qualified legal professional — not a supplement vendor, and certainly not a forum.
The rest of the responsible-use framework — no depressant mixing, no machinery after use, 21+ only, breaks for regular users — is in the responsible use guide and the FAQ center. And if you do buy, buy the verifiable kind: batch COAs, honest mg labels, 21+ policy — the 9-point checklist, applied to the shop. Check your state rules first.